Plasma Coenzyme Q10 Levels in Patients With Multiple System Atrophy | Zendy

Jun Mitsui | Zendy; Takashi Matsukawa | Zendy; Tsutomu Yasuda | Zendy; Hiroyuki Ishiura | Zendy; Shoji Tsuji | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Plasma Coenzyme Q10 Levels in Patients With Multiple System Atrophy

Author(s) -

Jun Mitsui,

Takashi Matsukawa,

Tsutomu Yasuda,

Hiroyuki Ishiura,

Shoji Tsuji

Publication year - 2016

Publication title -

jama neurology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.298

H-Index - 231

eISSN - 2168-6157

pISSN - 2168-6149

DOI - 10.1001/jamaneurol.2016.1325

Subject(s) - medicine , coenzyme q10 , parkinsonism , gastroenterology , atrophy , pathogenesis , parkinson's disease , disease

Multiple system atrophy (MSA) is an intractable neurodegenerative disease characterized by autonomic failure in addition to various combinations of parkinsonism, cerebellar ataxia, and pyramidal dysfunction. It has recently been reported that functionally impaired variants of COQ2, which encodes an essential enzyme in the biosynthetic pathway of coenzyme Q10 (CoQ10), are associated with MSA. However, little is known about the role of CoQ10 in the pathogenesis of MSA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research